EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

Deborah Dowell, Kathleen R Ragan, Christopher M Jones, Grant T Baldwin, Roger Chou

MMWR. Recommendations and Reports · 04.11.2022 · 71 (3) · 1-95

DOI: 10.15585/mmwr.rr7103a1 ↗

Kurz gefasst

Leitlinie in der Zeitschrift MMWR. Recommendations and Reports, online erschienen am 04.11.2022. Verfasst von Deborah Dowell und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Chronic Pain, Opioid-Related Disorders. Die Arbeit wurde bisher 1892-mal zitiert (Crossref) und nennt 540 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This guideline provides recommendations for clinicians providing pain care, including those prescribing opioids, for outpatients aged ≥18 years. It updates the CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016 (MMWR Recomm Rep 2016;65[No. RR-1]:1-49) and includes recommendations for managing acute (duration of 3 months) pain. The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care. The guideline addresses the following four areas: 1) determining whether or not to initiate opioids for pain, 2) selecting opioids and determining opioid dosages, 3) deciding duration of initial opioid prescription and conducting follow-up, and 4) assessing risk and addressing potential harms of opioid use. CDC developed the guideline using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework. Recommendations are based on systematic reviews of the scientific evidence and reflect considerations of benefits and harms, patient and clinician values and preferences, and resource allocation. CDC obtained input from the Board of Scientific Counselors of the National Center for Injury Prevention and Control (a federally chartered advisory committee), the public, and peer reviewers. CDC recommends that persons with pain receive appropriate pain treatment, with careful consideration of the benefits and risks of all treatment options in the context of the patient's circumstances. Recommendations should not be applied as inflexible standards of care across patient populations. This clinical practice guideline is intended to improve communication between clinicians and patients about the benefits and risks of pain treatments, including opioid therapy; improve the effectiveness and safety of pain treatment; mitigate pain; improve function and quality of life for patients with pain; and reduce risks associated with opioid pain therapy, including opioid use disorder, overdose, and death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic PainOpioid-Related DisordersAdolescentAdultHumansAnalgesics, OpioidCenters for Disease Control and Prevention, U.S.Quality of LifeUnited States

Substanzen

Analgesics, Opioid

Zitieren

APA

Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022). CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR. Recommendations and Reports, 71(3), 1-95. https://doi.org/10.15585/mmwr.rr7103a1

Vancouver

Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR. Recommendations and Reports. 2022;71(3):1-95. doi:10.15585/mmwr.rr7103a1

BibTeX
@article{Dowell2022,
  author = {Dowell, Deborah and Ragan, Kathleen R and Jones, Christopher M and Baldwin, Grant T and Chou, Roger},
  title = {CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022},
  journal = {MMWR. Recommendations and Reports},
  year = {2022},
  volume = {71},
  number = {3},
  pages = {1--95},
  doi = {10.15585/mmwr.rr7103a1}
}
Kostenlos starten →